Latest Market Sensitivity News

American Tungsten and Antimony Ltd has addressed discrepancies between initial visual estimates and assay results for stibnite mineralisation at its Antimony Canyon Project, revealing challenges in distinguishing mineral types visually and outlining steps to improve reporting accuracy.

Electro Optic Systems Holdings Limited (EOS) has responded to ASX concerns over insufficient details in its December 2025 announcement about a major US$80 million high energy laser contract, prompting a review and update of its continuous disclosure policy.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

Vinyl Group Limited has responded to ASX concerns after confidential details of its Val Morgan Digital acquisition leaked prematurely to the media, prompting a review of its disclosure controls.

Astron Limited has released updated Mineral Resource and Ore Reserve estimates for its Donald Project, highlighting increased production forecasts for critical heavy rare earth elements. The project remains shovel ready, backed by comprehensive feasibility studies and regulatory approvals.

TasFoods has announced a delay in lodging its 2025 annual report due to an ongoing, material sale transaction, keeping its shares suspended until further notice.

BPM Minerals has responded to ASX scrutiny over the timing and materiality of its Bonnie & Clyde tenement grant announcement and related capital raising, confirming adherence to continuous disclosure rules.

Titanium Sands Limited has responded to ASX inquiries following a sharp share price drop and increased trading volume, confirming no undisclosed price-sensitive information. The company highlighted an unrelated Sri Lankan Supreme Court petition on illegal mining near its pending Mannar Island project.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Web Travel Group has responded to an ASX price query following significant share price swings, confirming no undisclosed material information exists. The company links recent trading activity to a publicly announced Spanish tax audit of its subsidiary.

Carnarvon Energy has announced the recommencement of its on-market share buy-back program, targeting up to 10% of its issued capital over the next year, funded from a healthy cash reserve.